Tumor mutation burden—from hopes to doubts

A Addeo, GL Banna, GJ Weiss�- JAMA oncology, 2019 - jamanetwork.com
Over the past few years, the development of immune checkpoint inhibitors has altered the
treatment paradigm in non–small cell lung cancer (NSCLC). Enrichment strategies have�…
Save Cite Cited by 105 Related articles

Tumor Mutation Burden-From Hopes to Doubts.

A Addeo, GL Banna, GJ Weiss�- JAMA Oncology, 2019 - europepmc.org
Tumor Mutation Burden-From Hopes to Doubts. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk�…
Cite

[CITATION][C] Tumor Mutation Burden-From Hopes to Doubts.

A Addeo, GL Banna, GJ Weiss�- JAMA oncology, 2019 - sonar.ch
Tumor Mutation Burden-From Hopes to Doubts. SONAR logo Log in Sign up EN English
Fran�ais Deutsch Italiano Back Tumor Mutation Burden-From Hopes to Doubts. Journal article�…
Cite

[CITATION][C] Tumor Mutation Burden-From Hopes to Doubts

A Addeo, GL Banna, GJ Weiss�- JAMA oncology, 2019 - pubmed.ncbi.nlm.nih.gov
Tumor Mutation Burden-From Hopes to Doubts Tumor Mutation Burden-From Hopes to Doubts
JAMA Oncol. 2019 Jul 1;5(7):934-935. doi: 10.1001/jamaoncol.2019.0626. Authors Alfredo�…
Cite